ADAG
Price
$2.66
Change
+$0.15 (+5.98%)
Updated
Mar 27, 6:59 PM EST
62 days until earnings call
BYSI
Price
$3.63
Change
+$0.02 (+0.55%)
Updated
Mar 27, 6:59 PM EST
34 days until earnings call
Ad is loading...

Analysis and predictions ADAG vs BYSI

Header iconADAG vs BYSI Comparison
Open Charts ADAG vs BYSIBanner chart's image
Adagene
Price$2.66
Change+$0.15 (+5.98%)
Volume$2.94K
CapitalizationN/A
BeyondSpring
Price$3.63
Change+$0.02 (+0.55%)
Volume$35.5K
CapitalizationN/A
View a ticker or compare two or three
ADAG vs BYSI Comparison Chart

Loading...

ADAGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BYSIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ADAG vs. BYSI commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and BYSI is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ADAG: $2.55 vs. BYSI: $3.63)
Brand notoriety: ADAG and BYSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 11% vs. BYSI: 24%
Market capitalization -- ADAG: $112.5M vs. BYSI: $141.63M
ADAG [@Biotechnology] is valued at $112.5M. BYSI’s [@Biotechnology] market capitalization is $141.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 1 FA rating(s) are green whileBYSI’s FA Score has 0 green FA rating(s).

  • ADAG’s FA Score: 1 green, 4 red.
  • BYSI’s FA Score: 0 green, 5 red.
According to our system of comparison, ADAG is a better buy in the long-term than BYSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 4 TA indicator(s) are bullish while BYSI’s TA Score has 5 bullish TA indicator(s).

  • ADAG’s TA Score: 4 bullish, 5 bearish.
  • BYSI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BYSI is a better buy in the short-term than ADAG.

Price Growth

ADAG (@Biotechnology) experienced а -10.53% price change this week, while BYSI (@Biotechnology) price change was +16.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ADAG is expected to report earnings on May 29, 2024.

BYSI is expected to report earnings on Jun 19, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ADAG with price predictions.
OPEN
A.I.dvisor published
a Summary for BYSI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BYSI($142M) has a higher market cap than ADAG($112M). BYSI YTD gains are higher at: 303.333 vs. ADAG (32.029). ADAG has higher annual earnings (EBITDA): -33.17M vs. BYSI (-64.49M). ADAG has more cash in the bank: 129M vs. BYSI (72.4M). BYSI has less debt than ADAG: BYSI (3.58M) vs ADAG (25.2M). ADAG has higher revenues than BYSI: ADAG (22.7M) vs BYSI (1.35M).
ADAGBYSIADAG / BYSI
Capitalization112M142M79%
EBITDA-33.17M-64.49M51%
Gain YTD32.029303.33311%
P/E RatioN/AN/A-
Revenue22.7M1.35M1,680%
Total Cash129M72.4M178%
Total Debt25.2M3.58M705%
FUNDAMENTALS RATINGS
BYSI: Fundamental Ratings
BYSI
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGBYSI
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
ADAGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BYSIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DASCX18.210.36
+2.02%
Dean Small Cap Value
HBLAX14.440.13
+0.91%
Hartford Balanced Income A
TQGIX17.310.12
+0.70%
T. Rowe Price Integrated Global Eq I
FTAAX11.730.04
+0.34%
Fidelity Advisor Asset Manager 30% A
CSGVX19.680.03
+0.15%
Columbia Select Global Equity Advisor

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and CYBN have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and CYBN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
+1.59%
CYBN - ADAG
22%
Poorly correlated
+0.19%
IGC - ADAG
22%
Poorly correlated
+1.88%
BCDA - ADAG
22%
Poorly correlated
-0.21%
ASLN - ADAG
22%
Poorly correlated
-0.63%
KROS - ADAG
22%
Poorly correlated
-2.30%
More